Sepsis eLearning materials showcased to Britain’s legislators at Westminster
The UK Sepsis Trust, which also uses the Create eLearning learning management system (LMS) to manage and monitor its courses, is making these e-learning materials available to help educate healthcare professionals, as well as members of the public.
In particular, at the end of April, The UK Sepsis Trust launched the Sepsis Savvy e-learning materials at an event in the Palace of Westminster. The audience included members of both Houses of Parliament, including the international businessman and former Deputy Chairman of the Conservative Party, Lord Ashcroft.
Founded in 2012 by a world leader in Sepsis, NHS consultant Dr Ron Daniels, The UK Sepsis Trust seeks to save lives and improve outcomes for survivors of Sepsis by instigating political change, educating healthcare professionals, raising public awareness and providing support for those affected by this devastating condition. The UK Sepsis Trust‘s expertise is based in the charity’s grassroots origins – its doctors and nurses have frontline, first-hand experience of the Sepsis problem and their passion is born of a comprehensive understanding of what needs to be done.
Create eLearning’s managing director, Mark Taggart, commented, “The Sepsis Trust does some really important work - and it’s gratifying that, to help it achieve its goals, the Trust has chosen to use Create eLearning’s expertise, both to produce its e-learning materials and to manage and monitor the materials’ use, via the Create eLearning platform.”
Incorporating a number of state-of-the-art advances in LMS technology, Create eLearning’s LMS is a hybrid platform that caters for coaching, mentoring, online and face-to-face training/ learning. Moreover, users can configure it to deliver learning materials anywhere in the world, in any language and on any delivery device.
“The platform’s offline, off-grid e-learning capabilities enables users to learn anywhere at any time – on trains and planes among other things – without the need for an internet connection or even a corporate email account,” said Mark Taggart. “The results of their learning activities can be uploaded to the LMS the next time they log on to the internet.”
About Create eLearning
The Create eLearning Platform is a learning management system (LMS) that claims to be “like Netflix for training and coaching”. This mobile-friendly e-learning portal allows users to build, host, deliver and track e-learning, as well as unite all their online training and coaching. The LMS software can be accessed in the Cloud, offline and off-grid – and it is SCORM compliant.
Founded by Mark Taggart, Create eLearning’s LMS makes it easy for users to understand all the skills and competencies within their business - and spot the gaps. It also allows users to build classes quickly and efficiently; build once and use over-and-over; track all training, coaching and mentoring actives and investments in one place; report on progress, link back to profit, customer satisfaction and efficiency, as well as make it easy for the best practices happening within their business to be more widely circulated.
Third Floor, 5 Saint Vincent Place, Glasgow, G1 2DH, Scotland
Tel: +44 141 275 4803; Email: firstname.lastname@example.org; Web: www.create-elearning.com
Contact: Mark Taggart, Create eLearning, +44 7754 933180; email@example.com
PR contact: Bob Little, Bob Little Press & PR, +44 1727 860405; firstname.lastname@example.org
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sepsis eLearning materials showcased to Britain’s legislators at Westminster here
News-ID: 339167 • Views: 831
More Releases from Create eLearning
The Sepsis Trust can save more lives with help from Create eLearning
Create eLearn ng’s mobile-friendly e-learning portal is helping The UK Sepsis Trust to achieve its aim of saving at least 13,500 lives every year in the UK. The UK Sepsis Trust (UKST) is committed to changing the way the UK’s National Health Service (NHS) deals with sepsis, as well as increasing public awareness and supporting those affected by sepsis. Georgina McNamara, the UKST’s Executive Lead Nurse for Education and one of
Create eLearning is re-confirmed as meeting the ISO 9001 quality standard
The mobile-friendly e-learning portal producer, Create eLearning, has passed its ISO 9001 surveillance audit. ISO 9001 is a quality management standard that helps organisations demonstrate that they deliver a consistent high level of service. In addition, Create eLearning has Investors in People (IIP) Silver Standard. It also adheres to IT security standards ISO2701, 21 CFR Part 11, HIPAA, EU Privacy Directive and Safe Harbor. Carol-Ann Stevenson, Head of the Customer Success Team
More Releases for Sepsis
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report. Get Sample Copy of this Report @
Sepsis Diagnosis Market - Latest Trends, Forecast
Stratview Research announces the launch of a new research report on the Sepsis Diagnosis Market: By Technology (Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers), By Type of Testing (Blood Culture Media, and Instruments), By Mode of Testing (Automated, Semi-Automated), By Site of Testing (Laboratory Based, Patient Bed Side (POC)), By Type of Sepsis (Pathogen) (Bacterial, Fungal), By Testing Facility (Hospitals, Clinics, and Others), By Region (North America, Western Europe, Asia-Pacific,
Sepsis Diagnosis Market - Latest Trends, Capability Assessment up to 2025
Stratview Research announces the launch of a new research report on the Sepsis Diagnosis Market. This extensive report from Stratview Research, studies the clinical diagnostics market - sepsis diagnosis over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the
Sepsis Therapeutics Market: Regional Analysis by 2021
Sepsis is a serious medical condition that is characterized by an uncontrolled immune response to an infection and is a leading cause of mortality worldwide. This irresistible immune response of a patient is also known as Systemic Inflammatory Response Syndrome (SIRS). In severe cases of sepsis, the infection leads to a significant drop in blood pressure named as septic shock. The septic shock will instantaneously lead to failure of other
Sepsis Therapeutics Market; Key Trends and Opportunities
Sepsis, also known as septicemia, is a life-threatening disease caused when the body responds to an infection. Sepsis leads to a series of reactions that causes widespread inflammation throughout the body and could result in septic shock, a medical emergency. Sepsis is categorized by the presence of numerous bacteria in the blood that are actively dividing. These changes could lead to organ dysfunction such as depression of heart, collapse of
A Study on Sepsis Diagnostics Market
According to the report “Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, the Global Sepsis Diagnostics Market was worth USD 370 million